Since ANP is the most relevant component of the family that is able to modulate blood pressure and contribute to hypertension development, it is therefore expected that ANP-based therapeutic approaches may give a significant contribution to the development of efficacious therapies against hypertension. This evidence concerns the gene NPPA and hypertensive disorder.